VA
GILD icon

Vident Advisory’s Gilead Sciences GILD Stock Holding History

Vident Advisory’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.6M Sell
162,497
-6,424
-4% -$900K 0.19% 102
2025
Q4 		$20.7M Buy
168,921
+24,832
+17% +$3.02M 0.19% 104
2025
Q3 		$16M Buy
144,089
+75,794
+111% +$8.62M 0.15% 127
2025
Q2 		$7.57M Buy
68,295
+28,788
+73% +$3.06M 0.09% 199
2025
Q1 		$4.43M Buy
39,507
+13,679
+53% +$1.41M 0.06% 263
2024
Q4 		$2.39M Sell
25,828
-29,112
-53% -$2.62M 0.04% 375
2024
Q3 		$4.61M Buy
54,940
+24,824
+82% +$1.89M 0.12% 166
2024
Q2 		$2.07M Sell
30,116
-9,748
-24% -$651K 0.06% 357
2024
Q1 		$2.92M Sell
39,864
-69,227
-63% -$5.32M 0.06% 301
2023
Q4 		$8.84M Buy
109,091
+1,266
+1% +$98.5K 0.22% 143
2023
Q3 		$8.08M Buy
+107,825
New +$8.29M 0.25% 131

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vident Advisory's GILD Position: Q1 2026 in Review

Vident Advisory reduced its Gilead Sciences (GILD) stake by 3.8% in Q1 2026, selling an estimated $900K and leaving 162,497 shares worth $22.6M. The position accounts for 0.19% of the portfolio, ranked #102.

Vident Advisory first reported a position in GILD in Q3 2023 and has held it in 11 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Vident Advisory held 162,497 shares of Gilead Sciences worth $22.6M as of Q1 2026.
  • Vident Advisory sold 6,424 Gilead Sciences shares in Q1 2026, an estimated $900K.
  • Gilead Sciences made up 0.19% of Vident Advisory's portfolio in Q1 2026, its #102 holding.
  • Vident Advisory first reported a position in Gilead Sciences in Q3 2023 and has held it in 11 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.